Pārskats
Akcijas cenas izmaiņa
24h
Šī brīža
Min
1.21
Max
1.37
Ienākumi | 3.7K -5.5M |
|---|---|
EPS | -0.68 |
EBITDA | 13K -4.4M |
Nākamie ieņēmumi | 2026. g. 13. aug. |
|---|
Tirgus kapitalizācija | 8.7M 21M |
|---|---|
Iepriekšējā atvēršanas cena | -9.21 |
Iepriekšējā slēgšanas cena | 1.36 |
Ziņu noskaņojums
By Acuity
39%
61%
125 / 340 Rangs Healthcare
CEL-SCI Corp Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Saistītās ziņas
2026. g. 3. aug. 23:56 UTC
Diversified Healthcare Trust reported second-quarter FFO of $0.16, exceeding estimates. Revenue fell short at $365.39 million, contributing to a decline in after-market trading.
Lasīt
2026. g. 3. aug. 23:56 UTC
First Solar Inc reported second-quarter revenue of $1.06 billion and a net profit of $423 million. Shares are higher in after-hours trading.
Lasīt
2026. g. 3. aug. 23:52 UTC
Microsoft shares are lower in after-market hours amid a class action lawsuit alleging misrepresentation of its Copilot products' performance and competitive position.
Lasīt
2026. g. 3. aug. 23:51 UTC
Marvell Technology plans a conference call for August 27, 2026, and an Investor Day on October 6, 2026. Shares are higher in after-market trading.
Lasīt
2026. g. 3. aug. 23:51 UTC
Rivian Automotive raises 2026 capital expenditure guidance to $1.7B-$1.8B, shares trade higher in after-market hours amid focus on cost management and production scaling.
Lasīt
2026. g. 3. aug. 23:51 UTC
JELD-WEN Holding Inc. reported second-quarter revenue of $817.8 million, exceeding forecasts. The company raised its full-year revenue guidance, boosting after-market trading sentiment.
Lasīt
2026. g. 3. aug. 23:51 UTC
Palantir Technologies reported Q2 revenue of $1.94 billion, exceeding expectations. Shares rose sharply in after-market hours following strong earnings and raised guidance.
Lasīt
2026. g. 3. aug. 23:51 UTC
Snap Inc. reported a narrower net loss of $163.96 million and revenue of $1.60 billion, exceeding expectations. Shares rose during after-market trading.
Lasīt
2026. g. 3. aug. 23:46 UTC
Novavax Inc is advancing in after-market trading as it shifts focus to licensing its Matrix-M adjuvant, attracting positive retail investor sentiment ahead of earnings.
Lasīt
2026. g. 3. aug. 23:46 UTC
CVS Health shares rose in after-market hours following a survey showing increased provider-payer trust scores and improved perceptions of digital tools in healthcare.
Lasīt
2026. g. 3. aug. 23:46 UTC
Alexandria Real Estate Equities reported a narrower net loss and FFO of $1.73, exceeding estimates. Shares traded higher in after-market hours.
Lasīt
2026. g. 3. aug. 23:46 UTC
Nova Ltd's after-market shares are higher, bolstered by strong analyst sentiment and a consensus price target of $603.38, reflecting a potential 54.4% return.
Lasīt
2026. g. 3. aug. 23:46 UTC
Realty Income Corp reported first-quarter revenue of nearly $1.55 billion, with adjusted funds from operations increasing to $1.06 billion. Shares were roughly flat after-market.
Lasīt
2026. g. 3. aug. 23:41 UTC
Teladoc Health remains effectively unchanged in after-market trading. Citigroup lowered its price target from $11.00 to $7.50 while maintaining a "neutral" rating.
Lasīt
2026. g. 3. aug. 23:41 UTC
Addus Homecare Corp reported Q2 revenue of $377.4 million and adjusted EPS of $1.73. Shares declined after the earnings announcement amid mixed market reactions.
Lasīt
2026. g. 3. aug. 23:41 UTC
Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.
Lasīt
2026. g. 3. aug. 23:41 UTC
DA Davidson raised its price target for First Business Financial Services to $80, contributing to higher shares in after-market trading.
Lasīt
2026. g. 3. aug. 23:41 UTC
Karyopharm Therapeutics shares are lower in after-market hours following the grant of restricted stock units to a new employee, raising potential dilution concerns.
Lasīt
2026. g. 3. aug. 23:41 UTC
Andersons Inc. shares rise in after-market trading following strong Q2 results, with adjusted net income of $73.6 million exceeding expectations.
Lasīt
2026. g. 3. aug. 23:41 UTC
BWX Technologies shares are lower in after-market hours following a revenue miss of $901.6 million and a divestiture of its medical business to Nordic Capital.
Lasīt
2026. g. 3. aug. 23:41 UTC
Williams Companies announced an agreement to acquire Momentum Midstream for up to $5.5 billion, boosting its natural gas infrastructure and supporting Gulf Coast demand.
Lasīt
2026. g. 3. aug. 23:41 UTC
Ichor Holdings shares lower in after-market trading following a revenue miss of $294.8 million and EPS of $0.03, below expectations.
Lasīt
2026. g. 3. aug. 23:31 UTC
Biomarin Pharmaceutical shares are lower in after-market hours amid concerns over stagnant operating margins and below-average returns on capital, raising investor caution.
Lasīt
2026. g. 3. aug. 23:31 UTC
Ameresco shares rose in after-market trading following strong Q2 results, with revenues of $515.5 million exceeding expectations and a record $1.8 billion in new project awards.
Lasīt
2026. g. 3. aug. 23:31 UTC
UBS raised its price target on Colgate-Palmolive Co to $109, maintaining a Buy rating. Shares are trading higher in after-market hours.
Lasīt
2026. g. 3. aug. 23:31 UTC
Grab Holdings reported strong Q2 results, with earnings per share of 6 cents and revenue of $997 million. Shares are higher in after-market hours.
Lasīt
2026. g. 3. aug. 23:31 UTC
Ultra Clean Holdings reported Q2 net income of $11.9 million and revenue of $644.9 million, raising its Q3 outlook to between $700 million and $750 million.
Lasīt
2026. g. 3. aug. 23:26 UTC
Vertex Pharmaceuticals reported second-quarter revenue of $3.33 billion, exceeding estimates. The company raised its full-year guidance to between $13.1 billion and $13.2 billion.
Lasīt
2026. g. 3. aug. 23:21 UTC
Banner Corp announces a buyback of up to 1.7 million shares, aiming to enhance long-term shareholder value. Shares are higher in after-market trading.
Lasīt
2026. g. 3. aug. 23:21 UTC
Inspire Medical Systems reported Q2 adjusted EPS of $0.14, exceeding expectations. The company raised its full-year EPS guidance to between $1.05 and $1.45.
Lasīt
Salīdzinājums
Cenas izmaiņa
CEL-SCI Corp Prognoze
Vērtējuma vienprātība
By TipRanks
0 ratings
0
Pirkt
0
Turēt
0
Pārdot
Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam CEL-SCI Corp — pēdējo 3 mēnešu laikā.
Noskaņojums
By Acuity
Ziņu noskaņojums
Liecība "Buļļu" tendencei
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Zem vidējā
Finanšu rādītāji
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$